Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma - Holthof, Lisa C.; van der Horst, Hilma J.; van Hal-van Veen, Susan E.; Ruiter, Ruud W.J.; Li, Fengzhi; Buijze, Marijke; Andersen, Morten N.; Yuan, Huipin; de Bruijn, Joost; van de Donk, Niels W.C.J.; Lokhorst, Henk M.; Zweegman, Sonja; et al. (Haematologica (Roma), 2020)